4C Medical Overview
- Founded
-
2015

- Status
-
Private
- Employees
-
28

- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$35.3M
- Investors
-
6
4C Medical General Information
Description
Developer of a novel minimally invasive system designed for the treatment of mitral regurgitation. The company's system directly addresses mitral regurgitation without replacing the native mitral valve to preserve the native mitral annulus and left ventricle, enabling doctors to help patients get access to a minimally invasive alternative for the treatment of mitral regurgitation.
Contact Information
Website
www.4cmed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Primary Office
- 6655 Wedgwood Road
- Suite 160
- Maple Grove, MN 55311
- United States
+1 (612) 000-0000
4C Medical Timeline
4C Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series C) | 15-Nov-2021 | $35.3M | 000.00 | Completed | Clinical Trials - General | |
4. Debt - PPP | 28-Apr-2020 | 00000 | 000.00 | Completed | Startup | |
3. Early Stage VC (Series B) | 02-Oct-2019 | 00.000 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series A) | 11-Sep-2018 | $17M | $29.1M | 0000 | Completed | Startup |
1. Seed Round | 11-May-2018 | $12.1M | $12.1M | 000.00 | Completed | Startup |
4C Medical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Seed | 10,913,919 | $0.000100 | $1.9 | $1.9 | 1x | $1.9 | 33.64% |
4C Medical Patents
4C Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020434022-A1 | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells | Pending | 06-Mar-2020 | 0000000000 | |
US-20210275297-A1 | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells | Pending | 06-Mar-2020 | 0000000000 | |
CA-3170394-A1 | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells | Pending | 06-Mar-2020 | 0000000000 | |
EP-4114307-A1 | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells | Pending | 06-Mar-2020 | 0000000000 | |
AU-2021231656-A1 | Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation | Pending | 05-Mar-2020 | A61F2/2418 |
4C Medical Executive Team (6)
4C Medical Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Buzz Benson | Self | Board Member | 000 0000 |
Jeffrey Chambers MD | 4C Medical | Founder, Chairman & Chief Medical Officer | 000 0000 |
Jonathan Chen | 4C Medical | Board Member | 000 0000 |
Rhonda Robb | Self | Board Member | 000 0000 |
William Hoffman | 4C Medical | Board Member | 000 0000 |
4C Medical Signals
4C Medical Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
AG Collective Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
MicroPort CardioFlow | Corporation | Minority | 000 0000 | 000000 0 | |
Roski Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
Yonghua Capital | Corporate Venture Capital | 000 0000 | 000000 0 | ||
Anges Québec | Angel Group | Minority | 000 0000 | 000000 0 |